COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI… (NCT07626268) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)- A Pilot Randomized Controlled Trial
160 participantsStarted 2026-06-01
Plain-language summary
The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.
The main questions this study aims to answer are:
* Does an AKI discharge summary template improve communication about AKI after hospital discharge?
* Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge?
* Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.
Researchers will compare four groups:
* Usual care
* An AKI discharge summary template
* A chat-based educational messaging program
* Both the AKI discharge summary template and the chat-based educational messaging program
Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 years or older
* Hospitalized with Stage 2 or Stage 3 acute kidney injury
* Kidney function has not returned to baseline at the time of hospital discharge
* Able to communicate in English
* Able to provide informed consent
* Willing and able to participate in study procedures independently or with assistance from a patient-designated care partner
Exclusion Criteria:
* Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
* End-stage kidney disease
* Kidney transplant recipient
* Currently pregnant
* Documented cognitive impairment that precludes informed consent
* Receiving hospice or comfort-focused end-of-life care
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on care coordination and communication after an AKI episode — can you help me understand whether that kind of structured follow-up support is something I'd benefit from, compared to the standard follow-up care I'd receive anyway?
2Since this is listed as 'not yet recruiting,' do you know when it's expected to open, and is it worth waiting for this study or should we focus on other next steps for my kidney care right now?
3The trial seems to be testing whether the intervention can be delivered successfully rather than proving it improves health outcomes — what does that mean for what I might actually gain by participating, versus just helping researchers figure out if the program is workable?
4Because this is a pilot feasibility study, the researchers are still working out the logistics of enrollment and retention — does that mean there's more uncertainty about what participation would involve day-to-day, and how much of my time and energy might it realistically require?
5Are there existing, proven approaches to AKI follow-up care and kidney health monitoring that I should be pursuing now, regardless of whether this trial opens and I'm ever considered for it?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility: Eligible patient enrollment
Timeframe: Enrollment period
2
Feasibility: Participant retention
Timeframe: Baseline to 3 months after discharge
3
Feasibility: Successful delivery of assigned intervention components
Timeframe: Hospital discharge through 4 weeks after discharge